宠物鸟健康市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球宠物鸟健康市场价值7.268亿美元，预计到2034年将以8.2%的复合年增长率成长，达到16亿美元。这得归功于人们对鸟类健康状况的日益重视，以及鸟类主人和兽医纷纷采取预防性护理方法。随着越来越多的人寻求鸟类疾病的早期诊断，影像技术、非侵入性诊断和行为评估的使用显着增加。随着预防性护理日益成为主流，诊断、营养科学和禽类医学的进步正在持续改变全球鸟类健康的管理方式。

人们对全面健康照护日益增长的兴趣，刺激了针对不同鸟类的专用补充剂、针对性治疗和个人化兽医策略的需求。如今，科技工具有助于早期发现疾病，延长鸟类寿命并提高整体生活品质。远距医疗解决方案和行动兽医服务弥补了医疗服务的差距，尤其是在偏远地区。以宠物鸟饲养为重点的教育推广有助于提高公众意识，从而提高治疗依从性，改善伴侣鸟的生活条件。所有这些因素共同支撑着市场的上升趋势。

2024年，製药领域以3.487亿美元的市场规模领先市场，反映出对各种禽类细菌和真菌感染的管理需求日益增长。这个领域持续见证药物剂型的创新—从口服药物到外用製剂，这些创新正在带来更好的治疗效果。持证禽科兽医数量的不断增长也带来了处方量的增加，促使製药公司拓展其产品线。此外，专为鸟类设计的抗寄生虫和营养疗法也越来越受到市场的青睐。

2024年，寄生虫感染占宠物鸟感染总数的40.8%，凸显了对宠物鸟健康的广泛影响。体内和体外的寄生虫持续威胁鸟类的健康。肠道蠕虫和原生动物引起的疾病常常导致食慾不振、消化问题和免疫力下降。随着人们对这些风险的认识不断提高，抗寄生虫解决方案的使用也日益增多，包括药物饲料、外用药物和预防性补充剂。

2024年，美国宠物鸟健康市场规模达2.729亿美元，这得益于宠物鸟拥有量的增加、兽医护理服务管道的改善以及消费者对预防性保健的日益关注。随着越来越多的主人为宠物鸟购买保险，定期体检和诊断逐渐成为常态。鸟类健康产品透过线上零售通路销售，扩大了消费者覆盖范围。

Vetnil、IDEXX、Vetafarm、Virbac、默克公司、INDICAL BIOSCIENCE、AdvaCare Pharma、Wildlife Computers、VioVet、CJ Wildlife、赛默飞世尔科技、HomeoPet 和 Pranidhi Veterinary Diagnostics 等公司正在透过开发针对特定物种的解决方案、推出教育平台和拓展兽医地位。许多公司投资禽类研发，以开发更有效的治疗方法，同时与兽医专业人士合作，改进产品交付并改善动物结果。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 提高对禽类健康与福利的认识
    • 鸟类收养和外来宠物趋势的增加
    • 禽类诊断和治疗的进展
  • 产业陷阱与挑战
    • 针对特定物种的兽药供应有限
    • 鸟类治疗费用高且保险普及率低
• 成长潜力分析
• 监管格局
• 川普政府关税
  • 对贸易的影响
    • 贸易量中断
    • 报復措施
  • 对产业的影响
    • 供应方影响（原料）
      • 主要材料价格波动
      • 供应链重组
      • 生产成本影响
    • 需求面影响（售价）
      • 价格传导至终端市场
      • 市占率动态
      • 消费者反应模式
  • 受影响的主要公司
  • 策略产业反应
    • 供应链重组
    • 定价和产品策略
    • 政策参与
  • 展望与未来考虑
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品和服务，2021-2034 年

• 主要趋势
• 製药
  • 药物
  • 疫苗
  • 营养补充品
• 诊断和监控
  • 诊断设备
  • 监控设备
  • 耗材
• 服务

第六章：市场估计与预测：按应用，2021-2034

• 主要趋势
• 寄生虫感染
• 细菌感染
• 其他应用

第七章：市场估计与预测：依最终用途，2021-2034

• 主要趋势
• 兽医医院和诊所
• 宠物鸟主人（家庭照顾）
• 鸟舍和鸟类保护区
• 其他最终用途

第八章：市场估计与预测：按地区，2021-2034

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• AdvaCare Pharma
• Bimeda
• CJ Wildlife
• Hidrolab
• HomeoPet
• IDEXX
• INDICAL BIOSCIENCE
• Meadow's Animal Healthcare
• Merck & Co.
• Pranidhi Veterinary Diagnostics
• Thermo Fisher Scientific
• Vetafarm
• vetagenix
• Vetnil
• VioVet
• Virbac
• Wildlife Computers
• Zhejiang Pushkang Biotechnology

The Global Pet Bird Health Market was valued at USD 726.8 million in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 1.6 billion by 2034, propelled by the increasing recognition of avian health conditions and the adoption of preventative care approaches by bird owners and veterinarians alike. With more people seeking early diagnosis for avian ailments, there has been a noticeable uptick in the use of imaging technologies, non-invasive diagnostics, and behavioral assessments. As preventive care becomes more mainstream, advancements in diagnostics, nutritional science, and avian medicine continue to transform how bird health is managed globally.

Increased interest in comprehensive wellness care fuels demand for specialized supplements, targeted treatments, and personalized veterinary strategies tailored to various bird species. Technological tools now assist with early disease detection, improving bird longevity and overall quality of life. Telehealth solutions and mobile veterinary services bridge care gaps, especially in remote regions. Educational outreach focused on pet bird husbandry helps in driving awareness, leading to higher treatment adherence and better living conditions for companion birds. Collectively, these factors are sustaining the market's upward trajectory.

The pharmaceuticals segment led the market with USD 348.7 million in 2024, reflecting the growing need to manage a range of avian bacterial and fungal infections. This segment continues to see innovation in drug formats-from oral treatments to topical formulations, which are delivering better therapeutic results. The growing number of certified avian veterinarians is increasing prescriptions, prompting pharmaceutical firms to broaden their product offerings. Additionally, antiparasitic and nutritional therapies specifically designed for birds are gaining traction in the market.

Parasitic infestations held a 40.8% share in 2024, underscoring their widespread impact on pet bird health. Both internal and external parasites continue to pose threats to avian wellness. Conditions caused by intestinal worms and protozoa often result in appetite loss, digestive issues, and weakened immunity. Rising awareness about these risks has led to greater use of anti-parasitic solutions, including medicated feeds, topical agents, and preventative supplements.

U.S. Pet Bird Health Market generated USD 272.9 million in 2024, supported by rising pet bird ownership, improved access to veterinary care, and increasing consumer focus on preventative wellness. With more owners seeking insurance for pet birds, routine checkups and diagnostics are becoming standard. The availability of bird health products through online retail channels expands consumer reach.

Companies like Vetnil, IDEXX, Vetafarm, Virbac, Merck & Co., INDICAL BIOSCIENCE, AdvaCare Pharma, Wildlife Computers, VioVet, CJ Wildlife, Thermo Fisher Scientific, HomeoPet, and Pranidhi Veterinary Diagnostics are strengthening their foothold by developing species-specific solutions, launching e-commerce platforms, and expanding veterinary education programs. Many invest in avian R&D to produce more effective treatments while collaborating with veterinary professionals to refine product delivery and improve animal outcomes.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising awareness of avian health and welfare
    • 3.2.1.2 Increase in bird adoption and exotic pet trends
    • 3.2.1.3 Advances in avian diagnostics and therapeutics
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Limited availability of species-specific veterinary drugs
    • 3.2.2.2 High treatment costs and low insurance penetration for birds
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Retaliatory measures
  • 3.5.2 Impact on the Industry
    • 3.5.2.1 Supply-side impact (raw materials)
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (selling price)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Products and Services, 2021-2034 ($ Mn)

• 5.1 Key trends
• 5.2 Pharmaceuticals
  • 5.2.1 Drugs
  • 5.2.2 Vaccines
  • 5.2.3 Nutritional supplements
• 5.3 Diagnostics and monitoring
  • 5.3.1 Diagnostic equipment
  • 5.3.2 Monitoring devices
  • 5.3.3 Consumables
• 5.4 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)

• 6.1 Key trends
• 6.2 Parasitic infestations
• 6.3 Bacterial infections
• 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021-2034 ($ Mn)

• 7.1 Key trends
• 7.2 Veterinary hospitals and clinics
• 7.3 Pet bird owners (home care)
• 7.4 Aviaries and bird sanctuaries
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 AdvaCare Pharma
• 9.2 Bimeda
• 9.3 CJ Wildlife
• 9.4 Hidrolab
• 9.5 HomeoPet
• 9.6 IDEXX
• 9.7 INDICAL BIOSCIENCE
• 9.8 Meadow's Animal Healthcare
• 9.9 Merck & Co.
• 9.10 Pranidhi Veterinary Diagnostics
• 9.11 Thermo Fisher Scientific
• 9.12 Vetafarm
• 9.13 vetagenix
• 9.14 Vetnil
• 9.15 VioVet
• 9.16 Virbac
• 9.17 Wildlife Computers
• 9.18 Zhejiang Pushkang Biotechnology